ARTICLE | Clinical News
Auryxia regulatory update
August 24, 2015 7:00 AM UTC
EMA’s CHMP recommended approval of Fexeric ferric citrate from Keryx to treat hyperphosphatemia in adults with chronic kidney disease (CKD). Keryx markets the oral ferric iron-based phosphate binder a...